Literature DB >> 20451587

Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma.

C König1, O Gavrilova-Ruch, G Segond von Banchet, R Bauer, M Grün, E Hirsch, I Rubio, S Schulz, S H Heinemann, H G Schaible, R Wetzker.   

Abstract

G protein-coupled opioid receptors undergo desensitization after prolonged agonist exposure. Recent in vitro studies of mu-opioid receptor (MOR) signaling revealed an involvement of phosphoinositide 3-kinases (PI3K) in agonist-induced MOR desensitization. Here we document a specific role of the G protein-coupled class IB isoform PI3Kgamma in MOR desensitization in mice and isolated sensory neurons. The tail-withdrawal nociception assay evidenced a compromised morphine-induced tolerance of PI3Kgamma-deficient mice compared to wild-type animals. Consistent with a role of PI3Kgamma in MOR signaling, PI3Kgamma was expressed in a subgroup of small-diameter dorsal root ganglia (DRG) along with MOR and the transient receptor potential vanilloid type 1 (TRPV1) receptor. In isolated DRG acute stimulation of MOR blocked voltage-gated calcium currents (VGCC) in both wild-type and PI3Kgamma-deficient DRG neurons. By contrast, following long-term opioid administration the attenuating effect of MOR was strongly compromised in wild-type DRG but not in PI3Kgamma-deficient DRG. Our results uncover PI3Kgamma as an essential modulator of long-term MOR desensitization and tolerance development induced by chronic opioid treatment in sensory neurons. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451587     DOI: 10.1016/j.neuroscience.2010.04.068

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor.

Authors:  Sreedhar Madishetti; Nadine Schneble; Christian König; Emilio Hirsch; Stefan Schulz; Jörg P Müller; Reinhard Wetzker
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

2.  Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.

Authors:  Kelly A Berg; Matthew P Rowan; Teresa A Sanchez; Michelle Silva; Amol M Patwardhan; Stephen B Milam; Kenneth M Hargreaves; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2011-04-12       Impact factor: 4.030

3.  PI3Kγ/AKT Signaling in High Molecular Weight Hyaluronan (HMWH)-Induced Anti-Hyperalgesia and Reversal of Nociceptor Sensitization.

Authors:  Ivan J M Bonet; Eugen V Khomula; Dionéia Araldi; Paul G Green; Jon D Levine
Journal:  J Neurosci       Date:  2021-08-20       Impact factor: 6.167

4.  Class I PI3K Biology.

Authors:  Tihitina Y Aytenfisu; Hannah M Campbell; Mayukh Chakrabarti; L Mario Amzel; Sandra B Gabelli
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

5.  Second messengers mediating high-molecular-weight hyaluronan-induced antihyperalgesia in rats with chemotherapy-induced peripheral neuropathy.

Authors:  Ivan J M Bonet; Larissa Staurengo-Ferrari; Dionéia Araldi; Paul G Green; Jon D Levine
Journal:  Pain       Date:  2021-12-06       Impact factor: 7.926

6.  Construction of a global pain systems network highlights phospholipid signaling as a regulator of heat nociception.

Authors:  G Gregory Neely; Shuan Rao; Michael Costigan; Norbert Mair; Ildiko Racz; Giedre Milinkeviciute; Arabella Meixner; Swetha Nayanala; Robert S Griffin; Inna Belfer; Feng Dai; Shad Smith; Luda Diatchenko; Stefano Marengo; Bernhard J Haubner; Maria Novatchkova; Dustin Gibson; William Maixner; J Andrew Pospisilik; Emilio Hirsch; Ian Q Whishaw; Andreas Zimmer; Vaijayanti Gupta; Junko Sasaki; Yasunori Kanaho; Takehiko Sasaki; Michaela Kress; Clifford J Woolf; Josef M Penninger
Journal:  PLoS Genet       Date:  2012-12-06       Impact factor: 5.917

Review 7.  Lipid kinases as therapeutic targets for chronic pain.

Authors:  Lipin Loo; Brittany D Wright; Mark J Zylka
Journal:  Pain       Date:  2015-04       Impact factor: 7.926

8.  Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.

Authors:  Thiago M Cunha; Guilherme R Souza; Andressa C Domingues; Eleonora U Carreira; Celina M Lotufo; Mani I Funez; Waldiceu A Verri; Fernando Q Cunha; Sergio H Ferreira
Journal:  Mol Pain       Date:  2012-02-08       Impact factor: 3.395

9.  Genetic enhancement of behavioral itch responses in mice lacking phosphoinositide 3-kinase-γ (PI3Kγ).

Authors:  Bolam Lee; Giannina Descalzi; Jinhee Baek; Jae-Ick Kim; Hye-Ryeon Lee; Kyungmin Lee; Bong-Kiun Kaang; Min Zhuo
Journal:  Mol Pain       Date:  2011-12-14       Impact factor: 3.395

10.  Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.

Authors:  Pavel Adamek; Mario Heles; Anirban Bhattacharyya; Monica Pontearso; Jakub Slepicka; Jiri Palecek
Journal:  J Neurosci       Date:  2022-01-18       Impact factor: 6.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.